If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
26.25    -0.25 (-0.94%)
Bid:
26.00
Ask:
26.50
Spread: 0.50 (1.923%)
Market Cap: £132.17m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Interim Results

6 Dec 2019 07:00

RNS Number : 9012V
Duke Royalty Limited
06 December 2019
Β 

6 December 2019

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Interim Results for the six months ended 30 September 2019

Β 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce its interim results for the six months ended 30 September 2019 ("H1 2019").

Highlights

Β·; Revenue of Β£5.9 million (H1 2018: Β£2.7 million) an increase of 119%

Β·; Positive net cash inflow from operations rose 195% to Β£3.9 million (H1 2018: Β£1.3 million)

Β·; Net profit before tax of Β£3.7 million (H1 2018: Β£1.1 million)

Β·; Two follow-up investments into Welltel Ireland Limited and Step Investments Limited completed, totalling Β£1.65 million

Β·; Extension of three senior loan agreements with existing royalty partners, increasing future cashflows

Β·; Entered into a new Β£30 million revolving facility agreement with existing debt provider, Honeycomb Investment Trust PLC, on improved terms, providing greater financial flexibility

Β·; Strengthened operational team to reflect the scale achieved during the period

Β·; Post period end, raised Β£17.45 million via a Placing, an Open Offer and a Retail Offer to build the Company's royalty portfolio and to pay down the inherited credit facility

DividendΒ Declaration

The Company is pleased to report that during the interim period, Duke paid quarterly dividends of 0.7p per share to shareholders on 17 April 2019 and 0.7p per share paid on 12 July 2019. Additionally, for the September 2019 quarterly dividend, the Board announced the Company's third increase to 0.75p per share. This increase was in line with its strategy to maintain a high and stable dividend.

Neil Johnson, CEO of Duke Royalty, said, "I am delighted to report that H1 2019's activities have materially increased our revenue, profitability and cashflow. Having entered the second half of the year with a strong pipeline of new royalty opportunities and greater financial flexibility, thanks to our new credit facility and our recent successful equity raise, we are confident that we can continue the rapid growth achieved to date. Importantly, we increased our dividend for the third time since inception, in line with our strategy, due to the follow-on investments made in existing royalty partners. We look forward to supporting our existing royalty partners further and making additional investments during the period to build on the rapid growth achieved to date."

Β 

For further information, please contactΒ www.dukeroyalty.com, or contact:

Β 

Duke Royalty Limited

Neil Johnson / Charlie Cannon BrookesΒ 

+44 (0) 1481 741 240

Cenkos Securities plcΒ 

(Nominated Adviser and Broker)

Julian Morse / Michael Johnson / Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

Newgate Communications

(PR)

Elisabeth Cowell/ Ian Silvera/ Megan Kovach

+44 (0) 20 3757 6882

Β 

Chairman's Statement

Β 

Β 

Duke Royalty's ("Duke") strategy is to provide its shareholders with exposure to capital growth and income by becoming the preferred and leading provider of royalty finance for companies in Europe and abroad.

Our sector focus currently covers:

Β 

Β·; Hospitality and Leisure;

Β·; Industrials;

Β·; Technology and Media;

Β·; Healthcare; and

Β·; Business Services.

Β 

Duke is the only UK-quoted diversified royalty company, meaning that it benefits from a first-mover advantage to secure compelling investment opportunities in the royalty financing sector in the UK and Europe.

Β 

Royalty finance, which provides capital and receives returns based on revenue performance of its investee companies over a long term, represents a Β£50 billion sector in North America. Due to the banks' historic unwillingness to lend to SMEs, the funding gap in Europe and abroad means that we represent an attractive financing solution for private growth businesses that want to retain control of their businesses without any refinancing risk. In turn, our business model provides investors with exposure to ambitious private companies with excellent track records of delivering growth.

Β 

One of the key selling points and differentiating factors about Duke's business model is that its investee companies (royalty partners) are able to service the obligations arising from the royalty contract entirely out of expected cash flows. This is different than other forms of debt which typically expect the company to repay the entire principal within five years, sometimes with amortisation periods starting within two years. In times of short term uncertainty, repayment of principal which cannot be managed through operational cash flow, presents risk to the business owner and makes Duke Royalty's long term capital solution a more attractive option for businesses.

Β 

Our business development team has continued to broaden awareness of the benefits of royalty finance across the corporate and corporate advisory community, building on the success we have experienced so far.

Β 

Operational Review

Β 

I am pleased to report the results for the Group for the six-month period ended 30 September 2019 ("Interim 2020"). Interim 2020 was a period of ongoing rapid development for the Company with revenue, profitability and cashflow all increasing materially year on year, as well as further deployment of capital into its royalty portfolio. The Group also strengthened its operational team.

Β 

Careful cost management during growth phase

Β 

The Company's operating cost base is carefully managed to ensure that each deal entered into by Duke is immediately accretive. While cash operating expenses increased from Β£0.57 million to Β£1.1 million period-on-period, this reflects the decision by management to scale-up its operating team to effectively manage its deal origination, execution and monitoring requirements. Operating expenses will continue to be kept under tight control.

Β 

Improvements to operational team

Β 

I am delighted to report that the operating team has been further strengthened during the period by the appointment of Hugo Evans as Duke's new Finance Director. Hugo brings with him a wealth of expertise having previously acted as a Group Finance Director to a Guernsey domiciled, AIM listed investment management company. His relevant financial experience will be extremely useful in helping Duke prudently navigate its way through this next phase of growth.

Β 

I am pleased to say that post Hugo's appointment, the existing operating team and central cost base has now reached a sustainable level for the foreseeable future. Going forward, the Group's profitability is now expected to benefit from this operational leverage as additional income is generated from its royalty partners.

Β 

Extensions to investments

Β 

During Interim 2020, the Group made extensions to three senior loan agreements with existing royalty partners, thereby increasing the amount of cash that Duke can expect to receive back from these investments over their life.

Β 

These agreements were made with existing partners Welltel (Ireland) Limited ("Welltel"), a telecommunications services company, media company Step Investments Limited ("Step Investments", formerly "the Pearl & Dean Group"), and Xtremepush Limited, a technology solutions company. Each of these partners were acquired via the Capital Step acquisition in February 2019.

Β 

Follow on investments

Β 

During the period, Duke also completed two small follow-on investments into both Welltel and Step Investments, totalling Β£1.65 million, further demonstrating the confidence that Duke has in the recently acquired Capital Step portfolio.

Β 

Financial Review

Β 

I am pleased to report that total income for the period under review was Β£5.9 million, which is an increase of 119% year on year. Moreover, total comprehensive income for the period increased by 246% year on year to Β£3.3 million, as did net cash inflow from operating activities which rose 195% year on year to Β£3.9 million.

Β 

As referenced in previous Chairman's reports, I have encouraged shareholders to focus on the "net cash inflow from operating activities" number as this provides a true reflection of the Company's operating performance, highlighting what cash has been generated from the Company's royalty and loan book minus all cash operating costs incurred to manage the Group. I also refer you to the adjusted earnings figure in Note 4, which provides shareholders with a more detailed breakdown of operating performance. Given the increasing amount of capital that has been deployed by Duke coupled with the positive adjustment factors being generated by the existing portfolio alongside a now largely fixed operating cost base, I am pleased to report that I expect this metric to continue its increase in future periods.

Β 

In September 2019, Duke announced that it had entered into a new Β£30 million revolving facility agreement with its existing debt provider, Honeycomb Investment Trust PLC (the "New Credit Facility"), on improved terms. The New Credit Facility has a five-year term expiring in September 2024 with straight line amortization beginning in year four. It also has an interest rate equal to one-month LIBOR plus 7.25% per annum, which represents an improvement of 225bps on the previous rate of 9.5%.

Β 

Importantly, the New Credit Facility has an accordion facility which, subject to various loan to value and NAV thresholds, could allow for it to increase to a total of Β£50 million.

Β 

Duke now has significant balance sheet flexibility given that it can draw on this credit line before going to the equity markets to raise additional capital. This thereby avoids the potentially damaging impact of "cash drag" for shareholders, which is always an area of focus for Duke management given the Company's ongoing high dividend yield.

Β 

Dividend

Β 

During the interim period, Duke paid quarterly dividends to shareholders of 0.7p per share on 17 April 2019 and 0.7p per share on 12 July 2019. Additionally, for the September 2019 quarterly dividend, the Board announced the Company's third increase to 0.75p per share.

Β 

This increase was in line with our strategy to maintain a high and stable dividend.

Β 

Outlook

Β 

Looking towards 2020, I am confident that the Company's momentum will continue as it seeks to further expand and balance its portfolio. Finally, it is pleasing to report that progress has continued post the period end, with a significant equity issue of Β£17.45 million which closed in October 2019 and a further capital deployment into Lynx Equity in November. With the aforementioned New Credit Facility, the Company now has the capital to deploy into new and existing royalty partners which the management team is focused on delivering for the rest of FY2020.

Β 

Although we continually assess the geopolitical uncertainties facing the UK and European business community, the Company is well-positioned to cope with challenging macroeconomic events due to the consistently low operating costs and tight controls which are central to our business model. As such, the future remains bright for the Company and I am looking forward to the additional positive news flow expected for the remainder of FY2020.

Β 

We are pleased to report another strong period of growth and progress by the Company. I am grateful for the ongoing support of our shareholders, royalty partners and network of corporate partners and advisers and we look forward to reporting on the Group's ongoing progress in future periods.

Β 

Nigel Birrell

Chairman

Β 

Β 

Β 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

Β 

FOR THE PERIOD ENDED 30 SEPTEMBER 2019

Β 

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

Note

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β 

Β£000

Β 

Β£000

Β 

Β£000

Income

Β 

Β 

Β 

Β 

Β 

Β 

Net change in fair value of financial assets and financial liabilities through profit and loss

7,15,18

5,089

Β 

5,676

Β 

2,483

Loan interest receivable

9

672

Β 

255

Β 

-

Other income

Β 

6

Β 

209

Β 

216

Foreign exchange movements

Β 

136

Β 

-

Β 

-

Total income

Β 

5,903

Β 

6,140

Β 

2,699

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Investment Expenses

Β 

Β 

Β 

Β 

Β 

Β 

Transaction costs

Β 

(208)

Β 

(1,508)

Β 

(436)

Royalty participation fees

15,18

-

Β 

(432)

Β 

(432)

Net foreign currency losses

Β 

-

Β 

(42)

Β 

(2)

Β 

Β 

(208)

Β 

(1,982)

Β 

(870)

Operating Expenses

Β 

Β 

Β 

Β 

Β 

Β 

Administration and personnel

17

(801)

Β 

(1,133)

Β 

(279)

Legal and professional

Β 

(315)

Β 

(509)

Β 

(234)

Other operating expenses

Β 

(139)

Β 

(203)

Β 

(92)

Β 

Β 

(1,255)

Β 

(1,845)

Β 

(605)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Operating profit

Β 

4,440

Β 

2,313

Β 

1,224

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Interest payable

16

(611)

Β 

(397)

Β 

(79)

Other finance costs

Β 

(140)

Β 

-

Β 

(93)

Profit for the period before tax

Β 

3,689

Β 

1,916

Β 

1,052

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Taxation expense

3

(406)

Β 

(119)

Β 

(102)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive income for the period

Β 

3,283

Β 

1,797

Β 

950

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Basic earnings per share (pence)

Β 

1.66

Β 

1.10

Β 

0.73

Diluted earnings per share (pence)

Β 

1.65

Β 

1.10

Β 

0.73

Β 

Β 

All income is attributable to the holders of the Ordinary Shares of the Company.

Β 

The notes on pages 12 to 24 form an integral part of these Condensed Consolidated Financial Statements.

Β 

Β 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

Β 

AS AT 30 SEPTEMBER 2019

Β 

Β 

Note

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

Β 

Β£000

Β 

Β£000

Β 

Β£000

Non-current assets

Β 

Β 

Β 

Β 

Β 

Β 

Goodwill

6

203

Β 

203

Β 

-

Financial assets at fair value through profit or loss

7

63,163

Β 

63,167

Β 

39,174

Loans receivable

8

9,052

Β 

8,993

Β 

-

Deferred tax asset

9

-

Β 

-

Β 

107

Β 

Β 

72,418

Β 

72,363

Β 

39,281

Current assets

Β 

Β 

Β 

Β 

Β 

Β 

Financial assets at fair value through profit or loss

7

9,106

Β 

8,065

Β 

5,609

Loans receivable

9

2,065

Β 

632

Β 

-

Trade and other receivables

10

260

Β 

178

Β 

712

Cash and cash equivalents

Β 

3,998

Β 

5,894

Β 

30,066

Β 

Β 

15,429

Β 

14,769

Β 

36,387

Current liabilities

Β 

Β 

Β 

Β 

Β 

Β 

Trade and other payables

11

250

Β 

714

Β 

469

Current tax liability

Β 

538

Β 

248

Β 

209

Financial liabilities at fair value through profit or loss

12

212

Β 

173

Β 

187

Borrowings

13

257

Β 

326

Β 

-

Β 

Β 

1,257

Β 

1,461

Β 

865

Non-current liabilities

Β 

Β 

Β 

Β 

Β 

Β 

Trade and other payables

11

480

Β 

440

Β 

-

Financial liabilities at fair value through profit or loss

12

1,172

Β 

1,193

Β 

1,214

Borrowings

13

11,470

Β 

11,365

Β 

-

Deferred tax liability

9

680

Β 

565

Β 

-

Β 

Β 

13,802

Β 

13,563

Β 

1,214

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net Assets

Β 

72,788

Β 

72,108

Β 

73,587

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Equity

Β 

Β 

Β 

Β 

Β 

Β 

Shares issued

14

102,044

Β 

102,044

Β 

101,918

Share based payment reserve

15

491

Β 

333

Β 

169

Warrant reserve

15

265

Β 

265

Β 

125

Retained losses

16

(30,012)

Β 

(30,534)

Β 

(28,623)

Total Equity

Β 

72,788

Β 

72,108

Β 

73,589

Β 

The notes on pages 12 to 24 form an integral part of these Condensed Consolidated Financial Statements.

Β 

Β 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

Β 

FOR THE PERIOD ENDED 30 SEPTEMBER 2019

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β 

Β£000

Β 

Β£000

Β 

Β£000

Cash flows from operating activities

Β 

Β 

Β 

Β 

Β 

Β 

Receipts from royalty investments

Β 

4,397

Β 

5,097

Β 

1,792

Receipts of interest from loan investments

Β 

625

Β 

257

Β 

-

Receipts from transaction costs reimbursed

Β 

6

Β 

308

Β 

168

Other interest income received

Β 

-

Β 

1

Β 

-

Payments for royalty participation fees

Β 

(78)

Β 

(161)

Β 

(81)

Operating expenses paid

Β 

(1,084)

Β 

(1,392)

Β 

(568)

Net cash inflow from operating activities

Β 

3,866

Β 

4,110

Β 

1,311

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flows from investing activities

Β 

Β 

Β 

Β 

Β 

Β 

Royalty investments advanced

Β 

(250)

Β 

(25,033)

Β 

(13,925)

Loan investments advanced

Β 

(1,400)

Β 

(3,057)

Β 

-

Payment for acquisition of subsidiaries, net of cash acquired

Β 

(321)

Β 

(4,274)

Β 

-

Transaction costs paid - royalty investments

Β 

(404)

Β 

(624)

Β 

(222)

Transaction costs paid - business combinations

Β 

-

Β 

(268)

Β 

-

Pre-royalty investment advanced

Β 

-

Β 

-

Β 

(605)

Gain on exercise of warrants

Β 

-

Β 

-

Β 

88

Payment to acquire equity investment

Β 

-

Β 

-

Β 

-

Proceeds from disposal of equity instruments

Β 

-

Β 

89

Β 

-

Interest income received

Β 

-

Β 

-

Β 

14

Net cash outflow from investing activities

Β 

(2,375)

Β 

(33,167)

Β 

(14,650)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flows from financing activities

Β 

Β 

Β 

Β 

Β 

Β 

Proceeds from share issue

Β 

-

Β 

44,010

Β 

44,010

Share issue costs

Β 

-

Β 

(2,398)

Β 

(2,345)

Dividends paid

Β 

(2,760)

Β 

(4,023)

Β 

(1,251)

Proceeds from loans

Β 

-

Β 

3,500

Β 

-

Redemption of loans

Β 

-

Β 

(9,109)

Β 

-

Interest paid

Β 

(662)

Β 

(172)

Β 

(79)

Other finance costs paid

Β 

-

Β 

-

Β 

(86)

Net cash (outflow)/inflow from financing activities

(3,422)

Β 

31,808

Β 

40,250

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net change in cash and cash equivalents

Β 

(1,931)

Β 

2,749

Β 

26,911

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at beginning of Period/year

Β 

5,894

Β 

3,165

Β 

3,165

Effect of foreign exchange on cash

Β 

35

Β 

(21)

Β 

(10)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at the end of Period/year

Β 

3,998

Β 

5,894

Β 

30,066

Β 

The notes on pages 12 to 24 form an integral part of these Condensed Consolidated Financial Statements.

Β 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITYΒ 

FOR THE PERIOD ENDED 30 SEPTEMBER 2019

Β 

Β 

Β 

Β 

Β 

Share-based

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Shares

Β 

payment

Β 

Warrant

Β 

Retained

Β 

Total

Β 

Note

issued

Β 

reserve

Β 

reserve

Β 

losses

Β 

equity

Β 

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

At 1 April 2018

Β 

60,303

Β 

130

Β 

125

Β 

(28,314)

Β 

32,244

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive income for the period

Β 

-

Β 

-

Β 

-

Β 

950

Β 

950

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Transactions with owners

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Shares issued for cash

11

44,000

Β 

-

Β 

-

Β 

-

Β 

44,000

Share issuance costs

11

(2,385)

Β 

-

Β 

-

Β 

-

Β 

(2,385)

Share based payments

12

-

Β 

39

Β 

-

Β 

-

Β 

39

Dividends

5

-

Β 

-

Β 

-

Β 

(1,259)

Β 

(1,259)

Total transactions with owners

Β 

41,615

Β 

39

Β 

-

Β 

(1,259)

Β 

40,395

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

At 30 September 2018

Β 

101,918

Β 

169

Β 

125

Β 

(28,623)

Β 

73,589

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive income for the period

Β 

-

Β 

-

Β 

-

Β 

847

Β 

847

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Transactions with owners

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Share issuance costs

11

(13)

Β 

-

Β 

-

Β 

-

Β 

(13)

Share based payments

12

139

Β 

164

Β 

-

Β 

-

Β 

303

Warrants issued

12

-

Β 

-

Β 

140

Β 

-

Β 

140

Dividends

5

-

Β 

-

Β 

-

Β 

(2,758)

Β 

(2,758)

Total transactions with owners

Β 

126

Β 

164

Β 

140

Β 

(2,758)

Β 

(2,328)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

At 31 March 2019

Β 

102,044

Β 

333

Β 

265

Β 

(30,534)

Β 

72,108

Β 

Β 

Β 

Β 

Β 

Β 

Share-based

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Shares

Β 

payment

Β 

Warrant

Β 

Retained

Β 

Total

Β 

Note

issued

Β 

reserve

Β 

reserve

Β 

losses

Β 

equity

Β 

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

At 1 April 2019

Β 

102,044

Β 

333

Β 

265

Β 

(30,534)

Β 

72,108

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive income for the period

Β 

-

Β 

-

Β 

-

Β 

3,283

Β 

3,283

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Transactions with owners

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Share based payments

12

-

Β 

158

Β 

-

Β 

-

Β 

158

Dividends

5

-

Β 

-

Β 

-

Β 

(2,761)

Β 

(2,761)

Total transactions with owners

Β 

-

Β 

158

Β 

-

Β 

(2,761)

Β 

(2,603)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

At 30 September 2019

Β 

102,044

Β 

491

Β 

265

Β 

(30,012)

Β 

72,788

Β 

Β 

The notes on pages 12 to 24 form an integral part of these Condensed Consolidated Financial Statements.

Β 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 30 SEPTEMBER 2019

Β 

1. General Information

Β 

Duke Royalty Limited ("Duke Royalty" or the "Company") is a closed-ended investment company with limited liability formed under the Companies (Guernsey) Law, 2008. The Company is domiciled in Guernsey. Its shares are traded on the AIM market of the London Stock Exchange.

Throughout the period, the "Group" comprised Duke Royalty Limited and its wholly owned subsidiaries; Duke Royalty UK Limited, Capital Step Holdings Limited, Capital Step Investments Limited, Capital Step Funding Limited, Capital Step Funding 2 Limited and Duke Royalty Employee Benefit Trust.

The Group's investing policy is to invest in a diversified portfolio of royalty finance and related opportunities

Β 

2. Significant accounting policies

Β 

1.1 Basis of preparation

Β 

The interim Condensed Consolidated Financial Statements of the Group have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting", as adopted by the European Union, and using the going concern basis of preparation. These interim financial statements do not contain all the information and disclosures as presented in the annual financial statements, and should be read in conjunction with the Consolidated Financial Statements of the Group for the year ended 31 March 2019, which have been prepared in accordance with International Financial Reporting Standards ("IFRS"), to the extent that they have been adopted by the European Union, and applicable Guernsey law.

Β 

The accounting policies adopted in the preparation of the interim Condensed Consolidated Financial Statements are consistent with those followed in the preparation of the Consolidated Financial Statements of the Group for the year ended 31 March 2019.

Β 

The Financial Statements have been prepared on a historical cost basis, except for the following:

Β 

Β·; Royalty investments - measured at fair value through profit or loss

Β·; Equity investments - measured at fair value through profit or loss

Β·; Royalty participation liabilities - measured at fair value through profit or loss

Β 

1.2 New and amended standards adopted by the Group

Β 

There were no new standards adopted by the Group during the reporting period.

Β 

3. Income tax

Β 

The Company has been granted exemption from Guernsey taxation. The Company's subsidiary in the UK is subject to taxation in accordance with relevant tax legislation.

Β 

Factors affecting income tax expense for the year

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Period to

Β 

Β 

Year to

Β 

Period to

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Profit on ordinary activities before tax

3,689

Β 

1,916

Β 

950

Β 

Β 

Β 

Β 

Β 

Β 

Tax using the Groups effective tax rate of 11.29% (2018: 10.53%, period to 30 September 2018: 10.73%)

417

Β 

202

Β 

102

Tax losses not recognised

-

Β 

(97)

Β 

-

Differential in tax rate

(11)

Β 

14

Β 

-

Β 

406

Β 

119

Β 

102

Β 

Β 

4. Earnings per share

Β 

Β 

Period to

Β 

Β 

Year to

Β 

Period to

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive income (Β£000)

3,283

Β 

1,797

Β 

950

Weighted average number of Ordinary Shares

Β 

Β 

Β 

Β 

Β 

in issue, excluding treasury shares (000s)

197,182

Β 

163,129

Β 

130,211

Basic earnings per share (pence)

1.66

Β 

1.10

Β 

0.73

Β 

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive income (Β£000)

3,283

Β 

1,797

Β 

950

Weighted average number of Ordinary Shares,

Β 

Β 

Β 

Β 

Β 

diluted for warrants in issue (000s)

199,182

Β 

163,244

Β 

130,309

Diluted earnings per share (pence)

1.65

Β 

1.10

Β 

0.73

Β 

Β 

Basic earnings per share is calculated by dividing total comprehensive income for the period by the weighted average number of shares in issue throughout the period. Diluted earnings per share represents the basic earnings per share adjusted for the effect of dilutive potential shares issuable on exercise of share options under the Company's share-based payment schemes, weighted for the relevant period.

Adjusted earnings per share

Adjusted earnings represents the Group's underlying performance from core activities. Adjusted earnings is the total comprehensive income adjusted for unrealised and non-core fair value movements, non-cash items and transaction-related costs, including royalty participation fees, together with the tax effects thereon.

Valuation and other non-cash movements such as those outlined are not considered by management in assessing the level of profit and cash generation of the Group. Additionally, IFRS 9 requires transaction-related costs to be expensed immediately whilst the income benefit is over the life of the asset. As such, an adjusted earnings measure is used which reflects the underlying contribution from the Group's core activities during the year.

Β 

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive income for the period

3,283

Β 

1,797

Β 

950

Β 

Β 

Β 

Β 

Β 

Β 

Unrealised fair value movements

(693)

Β 

(651)

Β 

(771)

Gain on warrants

-

Β 

(88)

Β 

(88)

Share-based payments

158

Β 

482

Β 

39

Transactions costs net of costs reimbursed

208

Β 

1,161

Β 

329

Royalty participation fees

-

Β 

432

Β 

432

Tax effect of the adjustments above at Group effective rate

37

Β 

(140)

Β 

8

Adjusted earnings

2,993

Β 

2,992

Β 

899

Β 

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

Adjusted earnings (Β£000)

2,993

Β 

2,992

Β 

899

Weighted average number of Ordinary Shares

Β 

Β 

Β 

Β 

Β 

in issue, excluding treasury shares (000s)

197,182

Β 

163,129

Β 

130,211

Adjusted earnings per share (pence)

1.52

Β 

1.83

Β 

0.69

Β 

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

Adjusted earnings (Β£000)

2,993

Β 

2,992

Β 

899

Weighted average number of Ordinary Shares,

Β 

Β 

Β 

Β 

Β 

diluted for warrants in issue (000s)

199,182

Β 

163,244

Β 

130,309

Diluted adjusted earnings per share (pence)

1.50

Β 

1.83

Β 

0.69

Β 

5. Dividends

Β 

The following interim dividends have been recorded in the period:

Β 

Β 

Β 

Β 

Dividend per

Β 

Dividends

Β 

Β 

Β 

share

Β 

payable

Β 

Β 

Β 

pence/share

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Record date

Payment date

Β 

Β 

Β 

Β 

3 April 2018

12 April 2018

Β 

0.6

Β 

581

29 June 2018

12 July 2018

Β 

0.7

Β 

678

Dividends payable for the period ended 30 September 2018

Β 

Β 

Β 

1,259

Β 

Β 

Β 

Β 

Β 

Β 

Record date

Payment date

Β 

Β 

Β 

Β 

28 September 2018

12 October 2018

Β 

0.7

Β 

1,378

28 December 2018

11 January 2019

Β 

0.7

Β 

1,380

Dividends payable for the period ended 31 March 2019

Β 

Β 

Β 

2,758

Β 

Β 

Β 

Β 

Β 

Record date

Payment date

Β 

Β 

Β 

Β 

5 April 2019

17 April 2019

Β 

0.7

Β 

1,380

28 June 2019

12 July 2019

Β 

0.7

Β 

1,381

Dividends payable for the period ended 30 September 2019

Β 

Β 

Β 

2,761

Β 

On 27 September 2019 the Company approved a further quarterly dividend of 0.75 pence per share, totalling Β£1,479,000, which was paid on 18 October 2018.

Β 

6. Goodwill

Β 

Goodwill

Β 

Β£000

Opening net book value at 1 April 2018 and 1 October 2018

-

Arising on business combination

203

Closing net book value at 31 March 2019 and 30 September 2019

203

Β 

Β 

Β 

7. Financial assets at fair value through profit or loss

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Non-current

Β 

Β 

Β 

Β 

Β 

Royalty investments

61,952

Β 

61,990

Β 

39,174

Equity investments

1,211

Β 

1,177

Β 

-

Β 

63,163

Β 

63,167

Β 

39,174

Current

Β 

Β 

Β 

Β 

Β 

Royalty investments

9,106

Β 

8,065

Β 

5,609

Β 

72,269

Β 

71,232

Β 

44,783

Β 

Net changes in fair value on financial assets at fair value through profit or loss:

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

On royalty investments

5,150

Β 

5,789

Β 

2,615

On equity investments

34

Β 

65

Β 

-

Total net gains

5,184

Β 

5,854

Β 

2,615

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Realised

4,396

Β 

5,185

Β 

1,792

Change in unrealised

788

Β 

669

Β 

823

Total net gains

5,184

Β 

5,854

Β 

2,615

Β 

Β 

Realised changes in fair value relate to cash amounts received under the Group's royalty financing agreements.

Β 

Royalty investments

Β 

The Group's royalty investments comprise royalty financing agreements with 12 (30 September 2018: five, 31 March 2019: 12) investees. Under the terms of these agreements the Group advances funds in exchange for annualised royalty distributions. The distributions are adjusted based on the change in the investees' revenues, subject to a floor and a cap. The financing is secured by way of fixed and floating charges over certain of the investees' assets. The investees are provided with buyback options, exercisable at certain stages of the agreements.

Β 

Equity investments

Β 

The Group's equity investments comprise unlisted shares and warrants in four of its royalty investment companies (30 September 2018: one, 31 March 2019: four)

Β 

The Group also still holds two (30 September 2018: three, 31 March 2019: two) unlisted investments in mining entities from its previous investment objectives. The Board does not consider there to be any future cash flows from the remaining investments and they are fully written down to nil value.

Β 

Β 

8. Loans receivable

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Non-current

9,052

Β 

8,993

Β 

-

Current

2,065

Β 

632

Β 

-

Β 

11,117

Β 

9,625

Β 

-

The Group's loans receivable comprise secured loans advanced to five entities (2018 - nil) in connection with the Group's royalty investments.

The loans comprise fixed rate loans of Β£8,760,000 which bear interest at rates of between 5% and 16% and one variable rate loan of Β£2,357,000 which bears interest at 14.5% over LIBOR. The total interest receivable during the period was Β£672,000 (period to 30 September 2018 - Β£nil).

The loans mature as follows:

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

In less than one year

2,065

Β 

632

Β 

-

In one to two years

-

Β 

4,241

Β 

-

In two to five years

9,052

Β 

4,752

Β 

-

Β 

11,117

Β 

9,625

Β 

-

Β 

9. Deferred tax

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Deferred tax (liability)/asset

(680)

Β 

(565)

Β 

107

Β 

Β 

The deferred tax asset arises due to a temporary timing differences on the treatment of transaction costs in the UK subsidiary. This deferred tax asset is expected to reverse over a 30 year period. The utilisation of this asset is dependent on sufficient future taxable profits being generated by the UK subsidiary.

Β 

10. Trade and other receivables

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Transaction costs reimbursed receivable

-

Β 

-

Β 

40

Prepayments and accrued income

260

Β 

178

Β 

58

Pre-royalty investment advances

-

Β 

-

Β 

614

Β 

260

Β 

178

Β 

712

Β 

Β 

11. Trade and other payables

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Current

Β 

Β 

Β 

Β 

Β 

Trade payables

5

Β 

160

Β 

77

Consideration on business acquisition

-

Β 

321

Β 

-

Transaction costs

63

Β 

99

Β 

-

Accruals and deferred income

182

Β 

136

Β 

392

Β 

250

Β 

714

Β 

469

Non-current

Β 

Β 

Β 

Β 

Β 

Transaction costs

480

Β 

440

Β 

-

Β 

480

Β 

440

Β 

-

Β 

Β 

12. Financial liabilities at fair value through profit or loss

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Royalty participation liability

Β 

Β 

Β 

Β 

Β 

Current

212

Β 

173

Β 

187

Non-current

1,172

Β 

1,193

Β 

1,214

Β 

1,384

Β 

1,366

Β 

1,401

Β 

Net changes in fair value on financial liabilities at fair value through profit or loss:

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Realised

78

Β 

161

Β 

-

Change in realised

17

Β 

17

Β 

132

Β 

95

Β 

178

Β 

132

Β 

Β 

13. Borrowings

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Secured loan

Β 

Β 

Β 

Β 

Β 

Current - accrued interest

257

Β 

326

Β 

-

Non-current

11,470

Β 

11,365

Β 

-

Β 

11,727

Β 

11,691

Β 

-

Β 

The secured loan had an interest rate of 9.5% over LIBOR per annum. This rate was lowered to 7.25% over LIBOR per annum following a restructuring of the facility, completed on 8 October 2019. The principal amount is repayable on 8 October 2024. The loan is secured by means of a fixed and floating charge over the assets of the Group.

Β 

14. Share capital

Β 

Β 

No. shares

Β 

Β£000

Authorised

Β 

Β 

Β 

Unlimited number of shares of no par value

-

Β 

-

Β 

Β 

Β 

Β 

Allotted, called up and fully paid

Β 

Β 

Β 

At 1 April 2018

96,877,459

Β 

60,303

Shares issued for cash during the period

100,000,000

Β 

44,000

Share issuance costs

-

Β 

(2,385)

Shares issued to Employee Benefit Trust during the period

1,025,000

Β 

-

At 30 September 2018

197,902,459

Β 

101,918

Shares issued for cash during the period

-

Β 

-

Share issuance costs

-

Β 

(13)

Shares issued to Employee Benefit Trust during the period

1,665,000

Β 

-

Shares issued to directors and key advisers as remuneration

305,000

Β 

139

At 31 March 2019

199,872,459

Β 

102,044

Shares issued for cash during the period

-

Β 

-

Share issuance costs

-

Β 

-

Shares issued to Employee Benefit Trust during the period

-

Β 

-

At 30 September 2019

199,872,459

Β 

102,044

Β 

There is a single class of shares. There are no restrictions on the distribution of dividends and the repayment of capital with respect to externally held shares. The shares held by The Duke Royalty Employee Benefit Trust are treated as treasury shares. The rights to dividends and voting rights have been waived in respect of these shares.

Β 

15. Equity-settled share-based payments

Β 

The following table shows the movements in the warrant reserve during the year:

Β 

Β 

Β 

Warrants

Β 

Β 

Β£000

Β 

Β 

Β 

At 1 April 2018

Β 

125

Issued during the period

Β 

140

At 1 September 2018

Β 

265

Issue during the period

Β 

-

At 1 April 2019 and 30 September 2019

Β 

265

Β 

No warrants were issued during the period to 30 September 2019.

Β 

The following table shows the movements in the share-based payment reserve during the period:

Β 

Β 

Β 

Share

Β 

Β 

Β 

Β 

Β 

options

Β 

LTIP

Β 

Total

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

At 1 April 2018

124

Β 

6

Β 

130

LTIP awards

-

Β 

39

Β 

39

At 30 September 2018

124

Β 

45

Β 

169

Β 

Β 

Β 

Β 

Β 

Β 

LTIP awards

-

Β 

152

Β 

152

Share options granted

12

Β 

-

Β 

12

At 31 March 2019

136

Β 

197

Β 

333

Β 

Β 

Β 

Β 

Β 

Β 

LTIP awards

-

Β 

158

Β 

158

At 30 September 2019

136

Β 

355

Β 

491

Β 

No options were granted in respect of the Company's equity-settled share-based payment schemes during the period ended 30 September 2019. The charge to the Consolidated Statement of Comprehensive Income for the period ended 30 September 2019 in respect of all equity settled share-based payment schemes was Β£158,000 (period ended 30 September 2018: Β£39,000, year ended 31 March 2019: Β£203,000).

Β 

16. Distributable reserves

Β 

Under Guernsey law, the Company can pay dividends provided it satisfies the solvency test prescribed by the Companies (Guernsey) Law, 2008. The solvency test considers whether the Company is able to pay its debts when they fall due, and whether the value of the Company's assets is greater than its liabilities. The Company satisfied the solvency test in respect of the dividends declared in the period.

Β 

17. Related parties

Β 

Directors fees

Β 

The following fees were payable to the Directors during the period:

Β 

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Short term remuneration

211

Β 

338

Β 

105

Share-based payments

144

Β 

213

Β 

39

Β 

355

Β 

551

Β 

144

Β 

Other related party transactions

Β 

The following amounts were paid to related parties during the period in respect of support services fees:

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Abingdon Capital Corporation

150

Β 

248

Β 

98

Arlington Group Asset Management Limited

50

Β 

62

Β 

12

Β 

200

Β 

310

Β 

110

Β 

Β 

Support Service Agreements with Abingdon Capital Corporation ("Abingdon"), a company of which Neil Johnson is a Director, and Arlington Group Asset Management Limited ("Arlington"), a company of which Charles Cannon Brookes is a Director, were signed on 16 June 2015. The services to be provided by both Abingdon and Arlington include global deal origination, vertical partner relationships and on-going investment management, including preparation of investment reports, performance data and compliance with the Company's investing policy.

Β 

Dividends

The following dividends were paid to related parties

Β 

Β 

Period to

Β 

Year to

Β 

Period to

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Directors1

147

Β 

270

Β 

125

Β 

1 Includes dividends paid to Abinvest Corporation, a wholly owned subsidiary of Abingdon, and Arlington

Β 

18. Fair value measurements

Β 

Fair value hierarchy

IFRS 13 requires disclosure of fair value measurements by level of the following fair value hierarchy:

Level 1: Inputs are quoted prices (unadjusted) in active markets for identical assets and liabilities that the entity can readily observe.

Level 2: Inputs are inputs other than quoted prices included within Level 1 that are observable for the asset, either directly or indirectly.

Level 3: Inputs that are not based on observable market date (unobservable inputs).

The Group has classified its financial instruments into the three levels prescribed as follows:

Β 

Β 

Β 

30-Sep-19

Β 

31-Mar-19

Β 

30-Sep-18

Β 

Level 3

Β 

Level 3

Β 

Level 3

Β 

(unaudited)

Β 

(audited)

Β 

(unaudited)

Β 

Β£000

Β 

Β£000

Β 

Β£000

Financial assets

Β 

Β 

Β 

Β 

Β 

Financial assets at fair value through profit or loss

Β 

Β 

Β 

Β 

Β 

- Royalty investments

71,058

Β 

70,054

Β 

44,783

- Equity investments

1,211

Β 

1,177

Β 

-

Β 

72,269

Β 

71,231

Β 

44,783

Financial liabilities

Β 

Β 

Β 

Β 

Β 

Financial liabilities at fair value through profit or loss

Β 

Β 

Β 

Β 

Β 

- Royalty participation instruments

1,384

Β 

1,367

Β 

1,401

Β 

1,384

Β 

1,367

Β 

1,401

Β 

The following table presents the changes in level 3 items for the periods ended 30 September 2019, 31 March 2019 and 30 September 2018:

Β 

Β 

Financial

Β 

Financial

Β 

Β 

Β 

assets

Β 

liabilities

Β 

Total

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

At 1 April 2018

23,569

Β 

(917)

Β 

22,652

Additions

20,392

Β 

(352)

Β 

20,040

Royalty income received

(1,792)

Β 

-

Β 

(1,792)

Net change in fair value

2,615

Β 

(132)

Β 

2,483

At 30 September 2018

44,784

Β 

(1,401)

Β 

43,383

Additions

11,108

Β 

-

Β 

11,108

Business combination

15,494

Β 

-

Β 

15,494

Royalty income received

(3,305)

Β 

-

Β 

(3,305)

Royalty participation liabilities paid

-

Β 

161

Β 

161

Proceeds from exercise of warrants

(88)

Β 

-

Β 

(88)

Net change in fair value

3,239

Β 

(126)

Β 

3,113

At 31 March 2019

71,232

Β 

(1,366)

Β 

69,865

Additions

250

Β 

-

Β 

250

Royalty income received

(4,397)

Β 

-

Β 

(4,397)

Royalty participation liabilities paid

-

Β 

78

Β 

78

Net change in fair value

5,184

Β 

(95)

Β 

5,089

At 30 September 2019

72,269

Β 

(1,384)

Β 

70,885

Β 

Β 

Valuation techniques used to determine fair values

The fair value of the Group's financial instruments is determined using discounted cash flow analysis and all the resulting fair value estimates are included in level 3.

Valuation processes

The main level 3 inputs used by the Group are derived and evaluated as follows:

Annual adjustment factors for royalty investments and royalty participation liabilities

These factors are estimated based upon the underlying past and projected performance of the royalty investee companies together with general market conditions.

Discount rates for financial assets and liabilities

Β 

These are initially estimated based upon the projected internal rate of return of the royalty investment and subsequently adjusted to reflect changes in credit risk determined by the Group's Investment Committee.

Changes in level 3 fair values are analysed at the end of each reporting period and reasons for the fair value movements are documented.

Valuation inputs and relationships to fair value

Β 

The following summary outlines the quantitative information about the significant unobservable inputs used in level 3 fair value measurements:

Royalty investments

The unobservable inputs are the annual adjustment factor and the discount rate. The range of annual adjustment factors used is 0.0% to 6.0% and the range of risk-adjusted discount rates is 12.4% to 18.8%.

Equity investments

Β 

Sensitivity analysis has not been performed on the Group's equity investments on the basis that they are not material to the Condensed Consolidated Financial Statements

Royalty participation instruments

The unobservable inputs are the annual adjustment factor and the discount rate used in the fair value calculation of the royalty investments. The range of annual adjustment factors used is 0.0% to 6.0% and the range of risk-adjusted discount rates is 13.5% to 18.8%.

Β 

19. Events after the financial reporting date

Β 

Dividends

On 18 October 2019 the Company paid a quarterly dividend of 0.75 pence per share.

Issuance of ordinary shares

On 31 October 2019 the Company issued 39,667,899 new Ordinary Shares at 44 pence each. A total of Β£16,526,000 was raised, net of issuance costs.

Follow-on royalty investments

On 31 October 2019 the Group announced a follow-on investment of Β£2.0 million into its royalty partner (Lynx UK) Limited.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
IR LELLBKLFLFBE
Date   Source Headline
16th Apr 20213:14 pmRNSResult of General Meeting and Issue of Equity
6th Apr 20215:17 pmRNSResult of PrimaryBid Offer and Total Voting Rights
1st Apr 20217:00 amRNSResult of Placing
31st Mar 20214:32 pmRNSPrimaryBid Offer
31st Mar 20214:30 pmRNSPlacing to raise a minimum of £30 million
31st Mar 20214:30 pmRNSExit of Investment into Royalty Partner
18th Mar 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
15th Mar 20217:00 amRNSIncreased £35 Million Revolving Credit Facility
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
1st Mar 20212:05 pmRNSSecond Price Monitoring Extn
1st Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSFollow-on investment into existing royalty partner
19th Feb 20217:00 amRNSHolding(s) in Company
16th Feb 20217:00 amRNSNew Royalty Partner
9th Feb 20212:36 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSTrading Update
22nd Jan 202111:44 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSFollow-on investment into existing Royalty Partner
11th Jan 20217:00 amRNSAppointment of Chief Investment Officer
24th Dec 20207:00 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:01 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:00 amRNSExit of Investment in Royalty Partner
9th Dec 20207:01 amRNSInterim Results
9th Dec 20207:00 amRNSReinstated Cash Dividend and Dividend Declaration
18th Nov 20207:01 amRNSInvestor Presentation
18th Nov 20207:00 amRNSNotice of Interim Results
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSTrading Update and Reinstatement of Cash Dividend
21st Oct 20202:34 pmRNSResult of Annual General Meeting
21st Oct 20207:00 amRNSAppointment of Joint Broker
15th Oct 20205:35 pmRNSHolding(s) in Company
14th Oct 20201:00 pmRNSDirector/PDMR Dealings
2nd Oct 20203:47 pmRNSIssue of Equity for Scrip Dividend
2nd Oct 202012:39 pmRNSLTIP, Issue of Equity, Director/PDMR Holdings
1st Oct 20201:25 pmRNSScrip Dividend Reference Price
25th Sep 20207:00 amRNSPosting of Report and Accounts and Notice of AGM
17th Sep 20207:01 amRNSFinancial 2020 Final Results
17th Sep 20207:00 amRNSDividend Declaration
16th Sep 20207:00 amRNSTrading Update
14th Sep 20207:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20207:00 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSFollow-on investment into existing royalty partner
6th Aug 20207:00 amRNSTrading Update and Notice of FY 2020 Results
5th Aug 20205:43 pmRNSHolding(s) in Company
27th Jul 20202:05 pmRNSSecond Price Monitoring Extn
27th Jul 20202:00 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSDirector/PDMR Shareholding
3rd Jul 20203:15 pmRNSIssue of Equity for Scrip Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.